Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases

Artur Evangelista; Marta Sitges; Guillaume Jondeau; Robin Nijveldt; Mauro Pepi; Hug Cuellar; Gianluca Pontone; Eduardo Bossone; Maarten Groenink; Marc R. Dweck; Jolien W. Roos-Hesselink; L. Mazzolai; Roland van Kimmenade; Victor Aboyans; Jose Rodríguez-Palomares

doi:10.1093/ehjci/jead024

Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases

Artur Evangelista^*
, Marta Sitges
, Guillaume Jondeau
, Robin Nijveldt
, Mauro Pepi
, Hug Cuellar
, Gianluca Pontone
, Eduardo Bossone
, Maarten Groenink
, Marc R. Dweck
, Jolien W. Roos-Hesselink
, L. Mazzolai
, Roland van Kimmenade
, Victor Aboyans
, Jose Rodríguez-Palomares

^*Corresponding author for this work

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

59 Citations (Scopus)

Abstract

Imaging techniques play a pivotal role in the diagnosis, follow-up, and management of aortic diseases. Multimodality imaging provides complementary and essential information for this evaluation. Echocardiography, computed tomography, cardiovascular magnetic resonance, and nuclear imaging each have strengths and limitations in the assessment of the aorta. This consensus document aims to review the contribution, methodology, and indications of each technique for an adequate management of patients with thoracic aortic diseases. The abdominal aorta will be addressed elsewhere. While this document is exclusively focused on imaging, it is of most importance to highlight that regular imaging follow-up in patients with a diseased aorta is also an opportunity to check the patient's cardiovascular risk factors and particularly blood pressure control.

Original language	English
Pages (from-to)	e65-e85
Journal	European heart journal. Cardiovascular Imaging
Volume	24
Issue number	5
DOIs	https://doi.org/10.1093/ehjci/jead024
Publication status	Published - 1 May 2023

Bibliographical note

Funding Information:
Conflict of interest: A.E.: Nothing to be declared. M.S.: Speaker and consultancy fees from Abbott (Heart Valve Disease), Edwards Lifesciences (Heart Valve Disease), Medtronic (Heart Valve Disease). Research funding from Bristol Myers Squibb (Atrial Fibrillation), Menarini (Education on Cardiovascular Diseases), Novartis (Heart Failure), Rovi (Heart Failure), Amgen (Hypercholesterolemia), Merck Sharp & Dohme (Hypercholesterolemia). V.A.: Speaker and consultancy fees from Bayer Healthcare (Antithrombotic therapies), Novo-Nordisk (Diabetes), Astrazeneca (Diabetes), Boehringer Ingelheim (Diabetes). E.B.: Nothing to be declared. H.C.: Nothing to be declared. M.R.D.: Speaker and consultancy fees from Beren, Silence Therapeutics (aortic stenosis), Jupiter Bioventures (coronary atherosclerosis), Novartis (aortic stenosis, coronary atherosclerosis), Pfizer (cardiac amyloidosis).

Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.

Access to Document

10.1093/ehjci/jead024

Fingerprint

Dive into the research topics of 'Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases'. Together they form a unique fingerprint.

Cite this

Evangelista, A., Sitges, M., Jondeau, G., Nijveldt, R., Pepi, M., Cuellar, H., Pontone, G., Bossone, E., Groenink, M., Dweck, M. R., Roos-Hesselink, J. W., Mazzolai, L., van Kimmenade, R., Aboyans, V., & Rodríguez-Palomares, J. (2023). Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. European heart journal. Cardiovascular Imaging, 24(5), e65-e85. https://doi.org/10.1093/ehjci/jead024

Evangelista, Artur ; Sitges, Marta ; Jondeau, Guillaume et al. / Multimodality imaging in thoracic aortic diseases : a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. In: European heart journal. Cardiovascular Imaging. 2023 ; Vol. 24, No. 5. pp. e65-e85.

@article{45e323444abb4e1ab1bc320eb32ee6cd,

title = "Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases",

abstract = "Imaging techniques play a pivotal role in the diagnosis, follow-up, and management of aortic diseases. Multimodality imaging provides complementary and essential information for this evaluation. Echocardiography, computed tomography, cardiovascular magnetic resonance, and nuclear imaging each have strengths and limitations in the assessment of the aorta. This consensus document aims to review the contribution, methodology, and indications of each technique for an adequate management of patients with thoracic aortic diseases. The abdominal aorta will be addressed elsewhere. While this document is exclusively focused on imaging, it is of most importance to highlight that regular imaging follow-up in patients with a diseased aorta is also an opportunity to check the patient's cardiovascular risk factors and particularly blood pressure control.",

author = "Artur Evangelista and Marta Sitges and Guillaume Jondeau and Robin Nijveldt and Mauro Pepi and Hug Cuellar and Gianluca Pontone and Eduardo Bossone and Maarten Groenink and Dweck, \{Marc R.\} and Roos-Hesselink, \{Jolien W.\} and L. Mazzolai and \{van Kimmenade\}, Roland and Victor Aboyans and Jose Rodr{\'i}guez-Palomares",

note = "Funding Information: Conflict of interest: A.E.: Nothing to be declared. M.S.: Speaker and consultancy fees from Abbott (Heart Valve Disease), Edwards Lifesciences (Heart Valve Disease), Medtronic (Heart Valve Disease). Research funding from Bristol Myers Squibb (Atrial Fibrillation), Menarini (Education on Cardiovascular Diseases), Novartis (Heart Failure), Rovi (Heart Failure), Amgen (Hypercholesterolemia), Merck Sharp \& Dohme (Hypercholesterolemia). V.A.: Speaker and consultancy fees from Bayer Healthcare (Antithrombotic therapies), Novo-Nordisk (Diabetes), Astrazeneca (Diabetes), Boehringer Ingelheim (Diabetes). E.B.: Nothing to be declared. H.C.: Nothing to be declared. M.R.D.: Speaker and consultancy fees from Beren, Silence Therapeutics (aortic stenosis), Jupiter Bioventures (coronary atherosclerosis), Novartis (aortic stenosis, coronary atherosclerosis), Pfizer (cardiac amyloidosis). Publisher Copyright: {\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.",

year = "2023",

month = may,

day = "1",

doi = "10.1093/ehjci/jead024",

language = "English",

volume = "24",

pages = "e65--e85",

journal = "European heart journal. Cardiovascular Imaging",

issn = "2047-2404",

publisher = "Oxford University Press",

number = "5",

}

Evangelista, A, Sitges, M, Jondeau, G, Nijveldt, R, Pepi, M, Cuellar, H, Pontone, G, Bossone, E, Groenink, M, Dweck, MR, Roos-Hesselink, JW, Mazzolai, L, van Kimmenade, R, Aboyans, V & Rodríguez-Palomares, J 2023, 'Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases', European heart journal. Cardiovascular Imaging, vol. 24, no. 5, pp. e65-e85. https://doi.org/10.1093/ehjci/jead024

Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. / Evangelista, Artur; Sitges, Marta; Jondeau, Guillaume et al.
In: European heart journal. Cardiovascular Imaging, Vol. 24, No. 5, 01.05.2023, p. e65-e85.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Multimodality imaging in thoracic aortic diseases

T2 - a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases

AU - Evangelista, Artur

AU - Sitges, Marta

AU - Jondeau, Guillaume

AU - Nijveldt, Robin

AU - Pepi, Mauro

AU - Cuellar, Hug

AU - Pontone, Gianluca

AU - Bossone, Eduardo

AU - Groenink, Maarten

AU - Dweck, Marc R.

AU - Roos-Hesselink, Jolien W.

AU - Mazzolai, L.

AU - van Kimmenade, Roland

AU - Aboyans, Victor

AU - Rodríguez-Palomares, Jose

N1 - Funding Information: Conflict of interest: A.E.: Nothing to be declared. M.S.: Speaker and consultancy fees from Abbott (Heart Valve Disease), Edwards Lifesciences (Heart Valve Disease), Medtronic (Heart Valve Disease). Research funding from Bristol Myers Squibb (Atrial Fibrillation), Menarini (Education on Cardiovascular Diseases), Novartis (Heart Failure), Rovi (Heart Failure), Amgen (Hypercholesterolemia), Merck Sharp & Dohme (Hypercholesterolemia). V.A.: Speaker and consultancy fees from Bayer Healthcare (Antithrombotic therapies), Novo-Nordisk (Diabetes), Astrazeneca (Diabetes), Boehringer Ingelheim (Diabetes). E.B.: Nothing to be declared. H.C.: Nothing to be declared. M.R.D.: Speaker and consultancy fees from Beren, Silence Therapeutics (aortic stenosis), Jupiter Bioventures (coronary atherosclerosis), Novartis (aortic stenosis, coronary atherosclerosis), Pfizer (cardiac amyloidosis). Publisher Copyright: © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.

PY - 2023/5/1

Y1 - 2023/5/1

N2 - Imaging techniques play a pivotal role in the diagnosis, follow-up, and management of aortic diseases. Multimodality imaging provides complementary and essential information for this evaluation. Echocardiography, computed tomography, cardiovascular magnetic resonance, and nuclear imaging each have strengths and limitations in the assessment of the aorta. This consensus document aims to review the contribution, methodology, and indications of each technique for an adequate management of patients with thoracic aortic diseases. The abdominal aorta will be addressed elsewhere. While this document is exclusively focused on imaging, it is of most importance to highlight that regular imaging follow-up in patients with a diseased aorta is also an opportunity to check the patient's cardiovascular risk factors and particularly blood pressure control.

AB - Imaging techniques play a pivotal role in the diagnosis, follow-up, and management of aortic diseases. Multimodality imaging provides complementary and essential information for this evaluation. Echocardiography, computed tomography, cardiovascular magnetic resonance, and nuclear imaging each have strengths and limitations in the assessment of the aorta. This consensus document aims to review the contribution, methodology, and indications of each technique for an adequate management of patients with thoracic aortic diseases. The abdominal aorta will be addressed elsewhere. While this document is exclusively focused on imaging, it is of most importance to highlight that regular imaging follow-up in patients with a diseased aorta is also an opportunity to check the patient's cardiovascular risk factors and particularly blood pressure control.

UR - https://www.scopus.com/pages/publications/85153803278

U2 - 10.1093/ehjci/jead024

DO - 10.1093/ehjci/jead024

M3 - Article

C2 - 36881779

AN - SCOPUS:85153803278

SN - 2047-2404

VL - 24

SP - e65-e85

JO - European heart journal. Cardiovascular Imaging

JF - European heart journal. Cardiovascular Imaging

IS - 5

ER -

Evangelista A, Sitges M, Jondeau G, Nijveldt R, Pepi M, Cuellar H et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. European heart journal. Cardiovascular Imaging. 2023 May 1;24(5):e65-e85. doi: 10.1093/ehjci/jead024

Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this